Spiriva Respimat tiotropium bromide: Phase II/III data

Top-line data from the double-blind, international Phase II/III NinoTinA-asthma trial in 101 patients ages 1-5 with symptomatic persistent asthma who were taking

Read the full 226 word article

How to gain access

Continue reading with a
two-week free trial.